These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36155491)

  • 1. Association of poorly controlled HbA1c with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease.
    Chen SJ; Chiang HY; Chen PS; Chang SN; Chen SH; Wu MY; Yeh HC; Ting IW; Tsai HC; Chen PC; Kuo CC
    PLoS One; 2022; 17(9):e0274605. PubMed ID: 36155491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of haemoglobin A1c trajectories on chronic kidney disease progression in type 2 diabetes.
    Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang SF; Subramaniam T; Sum CF; Lim SC
    Nephrology (Carlton); 2019 Oct; 24(10):1026-1032. PubMed ID: 30565819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease.
    Limkunakul C; de Boer IH; Kestenbaum BR; Himmelfarb J; Ikizler TA; Robinson-Cohen C
    J Diabetes Complications; 2019 Apr; 33(4):296-301. PubMed ID: 30795915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD.
    Heo GY; Koh HB; Kim HW; Park JT; Yoo TH; Kang SW; Kim J; Kim SW; Kim YH; Sung SA; Oh KH; Han SH
    Diabetes Metab J; 2023 Jul; 47(4):535-546. PubMed ID: 37096377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.
    Navaneethan SD; Schold JD; Jolly SE; Arrigain S; Winkelmayer WC; Nally JV
    Am J Kidney Dis; 2017 Aug; 70(2):191-198. PubMed ID: 28196649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HbA
    Lee MY; Huang JC; Chen SC; Chiou HC; Wu PY
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study.
    Tang M; Berg AH; Zheng H; Rhee EP; Allegretti AS; Nigwekar SU; Karumanchi SA; Lash JP; Kalim S
    Am J Kidney Dis; 2024 Sep; 84(3):329-338. PubMed ID: 38518919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Complication and Glycemic Control in Korean Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort Study.
    Kim YA; Lee Y; Seo JH
    J Diabetes Res; 2020; 2020():9806790. PubMed ID: 32685562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages.
    Ooi SW; Yeh ST; Chang YH; Li CY; Chen HF
    PLoS One; 2022; 17(8):e0272137. PubMed ID: 35951657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Glycemic Control Trajectory with Short-Term Mortality in Diabetes Patients with High Cardiovascular Risk: a Joint Latent Class Modeling Study.
    Raghavan S; Liu WG; Berkowitz SA; Barón AE; Plomondon ME; Maddox TM; Reusch JEB; Ho PM; Caplan L
    J Gen Intern Med; 2020 Aug; 35(8):2266-2273. PubMed ID: 32333313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.
    Trivin C; Metzger M; Haymann JP; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Stengel B; Thervet E;
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):957-64. PubMed ID: 25979978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus.
    Rhee JJ; Zheng Y; Montez-Rath ME; Chang TI; Winkelmayer WC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28592463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease.
    Tang M; Berg A; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Kalim S
    Diabetes Care; 2023 Jan; 46(1):130-137. PubMed ID: 36399777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Hemoglobin A1c Trajectories on Future Outcomes in a 10-Year Cohort With Type 2 Diabetes Mellitus.
    Ma C; Zhang W; Xie R; Wan G; Yang G; Zhang X; Fu H; Zhu L; Lv Y; Zhang J; Li Y; Ji Y; Gao D; Cui X; Wang Z; Chen Y; Yuan S; Yuan M
    Front Endocrinol (Lausanne); 2022; 13():846823. PubMed ID: 35450420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Long-term HbA
    Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
    Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
    Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
    Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol.
    Hamada S; Gulliford MC
    J Am Geriatr Soc; 2016 Jul; 64(7):1425-31. PubMed ID: 27295278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
    Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
    Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the best predictor of mortality in patients with type 2 diabetes and chronic kidney disease: mean, variability of HbA1c or HbA1c-Hemoglobin ratio?
    Ooi SW; Lee MT; Chang YY; Chang CH; Chen HF
    BMC Nephrol; 2024 Jul; 25(1):246. PubMed ID: 39085774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.